Article
The therapeutic potential of targeting the CHD protein family in cancer.
Pharmacology & therapeutics - 1 Apr 2024
Zhang Min, Wu Kaiyuan, Zhang Weijie, Lin Xia, Cao Qi, Zhang Lili, Chen Kaifu
Abstract excerpt
Accumulating evidence indicates that epigenetic events undergo deregulation in various cancer types, playing crucial roles in tumor development. Among the epigenetic factors involved in the epigenetic remodeling of chromatin, the chromodomain helicase DNA-binding protein (CHD) family frequently exhibits gain- or loss-of-function mutations in distinct cancer types. Therefore, targeting CHD remodelers holds the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
